PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-May-2026 Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 ACCESS Newswire
07-May-2026 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 ACCESS Newswire
07-May-2026 TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis Businesswire
07-May-2026 WellSky® Wins “Home Healthcare Innovation Award” from MedTech Breakthrough for AI-Powered Ambient Listening and Transcription Businesswire
07-May-2026 VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026 Businesswire
07-May-2026 Fujifilm Develops Novel Screening Platform to Identify High-Affinity Cyclic Peptides for Challenging Membrane Protein Targets   Businesswire
07-May-2026 Phillips Medisize to Showcase Advances in Inhalation and Dry Powder Inhaler Innovations at Respiratory Drug Delivery (RDD) 2026 Businesswire
07-May-2026 Mission Bio De-risks CRISPR-Engineered T Cells Through Single-Cell Analysis of Genomic Edits and Gene Expression Businesswire
07-May-2026 eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials Businesswire
07-May-2026 ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver Businesswire
07-May-2026 Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel Businesswire
07-May-2026 Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results Businesswire
07-May-2026 ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines Businesswire
07-May-2026 VanEck Launches WARP ETF for Access to Rapidly Expanding Space Economy Businesswire
07-May-2026 Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development Businesswire
07-May-2026 Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities Businesswire
07-May-2026 ImmunityBio Reports Record Q1 2026 Results: Net Product Revenue Increased Nearly 2.7x Year-Over-Year to $44 Million in Q1 2026 Expanding on the 2025 Full Year 700% Year-Over-Year Revenue Growth; Cash and Marketable Securities Total $381 Million Businesswire
07-May-2026 Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates Businesswire
07-May-2026 Ukko Announces First Participant Dosed in Phase 1/2a Clinical Study Evaluating UKK-0018 for Peanut Allergy Treatment Businesswire
07-May-2026 Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance Businesswire